Simfibrate: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{drugbox | {{drugbox | ||
| IUPAC_name = 3-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxypropyl 2-(4-chlorophenoxy)-2-methylpropanoate | | IUPAC_name = 3-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxypropyl 2-(4-chlorophenoxy)-2-methylpropanoate | ||
| Line 25: | Line 24: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
{{CMG}} | __NOTOC__ | ||
{{SI}} | |||
{{CMG}} | |||
==Overview== | ==Overview== | ||
'''Synonyms and related keywords:''' 1,3-propanediol bis(alpha-p-chlorophenoxyisobutyrate); CLY 503; CLY-503; Cholesolvin | '''Synonyms and related keywords:''' 1,3-propanediol bis(alpha-p-chlorophenoxyisobutyrate); CLY 503; CLY-503; Cholesolvin | ||
'''Simfibrate''' is a [[fibrate]]. As May 20<sup>th</sup>, 2008 there is no approved drug form for human use. | '''Simfibrate''' is a [[fibrate]]. As May 20<sup>th</sup>, 2008 there is no approved drug form for human use. | ||
==References== | |||
{{reflist|2}} | |||
{{Lipid modifying agents}} | {{Lipid modifying agents}} | ||
[[Category:Drug]] | |||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Fibrates]] | [[Category:Fibrates]] | ||
Revision as of 16:46, 27 July 2014
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C23H26Cl2O6 |
| Molar mass | 469.354 g/mol |
|
WikiDoc Resources for Simfibrate |
|
Articles |
|---|
|
Most recent articles on Simfibrate |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Simfibrate at Clinical Trials.gov Clinical Trials on Simfibrate at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Simfibrate
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Simfibrate Discussion groups on Simfibrate Patient Handouts on Simfibrate Directions to Hospitals Treating Simfibrate Risk calculators and risk factors for Simfibrate
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Simfibrate |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Synonyms and related keywords: 1,3-propanediol bis(alpha-p-chlorophenoxyisobutyrate); CLY 503; CLY-503; Cholesolvin
Simfibrate is a fibrate. As May 20th, 2008 there is no approved drug form for human use.
References
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drug
- Cardiovascular Drugs
- Fibrates